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AbstrACt
Objectives There are more than 7000 rare diseases in 
the USA, and they are prevalent in 8% of the population. 
Due to life-threatening risk and limited therapies, early 
detection and treatment are critical. The purpose of this 
study was to explore characteristics of visits for patients 
with rare diseases seen by primary care physicians (PCPs).
Design The study used a cross sectional study using a 
national representative dataset, the National Ambulatory 
Medical Care Survey for the years 2012–2014.
setting Primary care setting.
Participants Visits to PCPs (n=22 306 representing 354 
507 772 office visits to PCPs).
Primary outcome measures Prevalence of rare diseases 
in visits of PCPs was the primary outcome. Bivariate 
analyses and logistic regression analyses were used to 
compare patients with rare diseases and those without 
rare diseases and examined characteristics of PCP visits 
for rare diseases and practice pattern.
results Among outpatient visits to PCPs, rare diseases 
account for 1.6% of the visits. The majority of patients 
with rare diseases were established patients (93.0%) and 
almost half (49.0%) were enrolled in public insurance 
programmes. The time spent in visits for rare diseases 
(22.4 min) and visits for more common diseases (21.3 min) 
was not significantly different (p=0.09). In an adjusted 
model controlling for patient characteristics (age, sex, 
types of insurance, reason for this visit, total number of 
chronic disease, having a rare disease and established or 
new patient), patients with rare diseases were 52% more 
likely to be referred to another provider (OR 1.52, 95% CI, 
1.01 to 2.28).
Conclusions Visits for rare diseases are uncommon in 
primary care practice. Future research may help to explain 
whether this low level of management of rare diseases in 
primary care practice is consistent with a goal of a broad 
scope of care.
IntrODuCtIOn 
Primary care physicians (PCPs) are trained 
to provide care for a broad scope of condi-
tions within their patient population. When 
PCPs maintain a broad scope of practice this 
safeguards access and quality of care for the 
general population. Some of these condi-
tions are managed directly by the PCP and 
with others the PCP coordinates the care for 
the patient. One recent study indicated that 
in 1 year, family physicians typically manage 
about 1700 diagnoses in office visits, with 100 
diagnoses managed frequently.1 
In addition to common, high preva-
lence diseases like diabetes, hypertension 
and arthritis, a substantial proportion of 
the general patient population, has a rare 
disease, or diseases. As of 2017, the National 
Institute of Health Genetic and Rare Disease 
(GARD) Information Center had identified 
7000 rare diseases, affecting approximately 
25–30 million people in the US population.2 
Rare diseases are categorised as life-threat-
ening, with only few limited effective thera-
pies available. In addition to the emotional 
and physical burden associated with diag-
nosis, patients with a rare disease often face 
financial burden due to the significant cost 
associated with drugs and therapies. As such, 
early detection and treatment are critical. 
For example, in one study, more than half 
of patients with rare diseases being seen at a 
PCP practice had been diagnosed with rare 
diseases at a PCP practice.3
However, to date there have been few 
studies investigating the role of PCPs in the 
strengths and limitations of this study
 ► This study is the first research to investigate char-
acteristics of patients with rare diseases seen in 
primary care practice and the association between 
physician referral and rare disease diagnosis.
 ► The study used population-based national represen-
tative data allowing for generalisability.
 ► Primary care physicians may play a vital role in pro-
viding continuous care and managing patients with 
rare diseases effectively.
 ► The study is limited to the actions recorded in one 
visit due to study design.
 ► The study was unable to determine if that referral 
is for a consult or part of a shared care relationship 
between primary care and specialty care.
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management of patients with rare diseases. The purpose 
of this study was to examine in a nationally representa-
tive sample of visits, the prevalence of rare diseases cared 
for in primary care practice as well as characteristics of 
patients and providers.
MethODs
This study used the National Ambulatory Medical Care 
Survey (NAMCS), a national representative dataset, for 
the years of 2012 to 2014. The NAMCS is a national prob-
ability sample survey of ambulatory medical care visits 
to office-based physicians that allows for national esti-
mates regarding medical care in the USA.3 Non-federally 
employed physicians defined by the American Medical 
Association and the American Osteopathic Association 
who were principally engaged in patient care activities 
and who are not specialised in anaesthesiology, pathology 
and radiology were eligible. Also physicians who are 
younger than 85 years of age at the time of the survey 
were eligible. Based on multistage probability design, 
eligible PCPs were selected and informed about the survey 
and those who agreed to participate to the survey were 
included in the data.3 NAMCS data are collected annu-
ally by the National Center for Health Statistics (NCHS). 
It is electronic record collected by the Census Bureau in 
the USA and multiple steps were implemented to process 
and review the data based on the NCHS protocol. The 
data estimates to be reliable met two criteria, (1) sample 
records should be at least 30, and (2) a relative SE should 
be 30% or less.3 The sample frame for NAMCS data in the 
years 2012–2014 was composed of PCPs who specialise in 
primary care (eg, general and family practice, internal 
medicine and paediatrics), and who identified themselves 
as the PCP of the patient.4 This list conforms to the defi-
nition used by the NAMCS to categorise primary care. 
Diagnosis was determined based upon the International 
Classification of Diseases (ICD)-9 codes and the diagnosis 
made by a PCP at a visit was electronically recorded in the 
patient record form. The patient report form provided 
pre-existing conditions, current diagnosis and new diag-
nosis.5 Thus, more than 30 diagnoses can be managed 
via this report form.6 Furthermore, this report form 
allows us to identify established patients who have visited 
before whereas it does not allow us to estimate numbers 
of previous visits. The unweighted sample size was 22 306 
representing 354 507 772 office visits to PCPs in the USA 
from 2012 to 2014.
rare disease
A rare disease is defined as a disease or a disorder that 
affects fewer than 200 000 people in the USA.2 7 For this 
study, diagnoses were identified as a rare disease using 
the list provided by the GARD Information Center.2 Two 
independent researchers and (ie, Dr Jo and Larson) and 
one family medicine physician (ie, Dr Carek) reviewed 
all new diagnosis in designated study years and identi-
fied rare diseases by comparing the list of GARD. With 
consensus agreements, rare diseases for the study were 
determined.
Independent variables
Demographics of patients seen by PCPs, such as age, 
gender and race/ethnicity, were used. Gender and race/
ethnicity (ie, non-Hispanic White, non-Hispanic Black, 
Hispanics and Others) were considered categorical vari-
ables whereas age was used as a continuous variable. In 
addition, their form of health insurance, major reason for 
the visit and total number of diagnosed chronic diseases 
were included as categorical variables. Health insurance 
was stratified into four categories: private insurance, 
public insurance such as Medicaid and Medicare, self-pay 
and others. Major reason for the visit was also catego-
rised into four groups: new problems, chronic problems, 
presurgery or postsurgery care and preventive care.
Providers’ characteristics including practice location 
(ie, urban or rural), referral to other providers (ie, yes or 
no) were examined. Time spent with providers in primary 
care setting was compared between patients with rare 
diseases and those without rare diseases. Time spent with 
providers in primary care is the length of the time the 
provider spent with the patient at the office and patient’s 
waiting time to see the provider, receive care from 
providers and prepare for a patient such as reviewing 
medical chart or physical examination were excluded.3
statistical analysis
To account for the complex survey design used in the 
NAMCS, a weighted variable was used to consider survey 
design effect. This allows for us to provide national esti-
mates of USA ambulatory healthcare visits to office-based 
physicians and community health centres.3 Also, it allows 
us to produce national estimates of the ambulatory health-
care use in the USA.3 The prevalence of rare disease seen 
in the primary care office visit was estimated. Χ2 tests were 
used to compare characteristics of PCPs who care for rare 
diseases against those who do not. Logistic regression was 
also employed to examine the association between PCP 
referral to other providers and patient diagnosis of a rare 
disease. All analyses were conducted in SAS V.9.4.
Patient and public involvement
Patients and/or public were not involved in this study.
results
The final sample was 22 306 representing 354 507 772 
office visits to PCPs in the USA from 2012 to 2014. A total of 
1508 PCPs participated to submit data for sample patient 
visits. Of the total patient visits to a PCP, a rare disease was 
noted in 1.6% of those visits. PCPs cared for 177 different 
rare diseases. Patients with rare diseases were signifi-
cantly older than those without rare diseases (age differ-
ence=8.3 years, p<0.01), while no significant differences 
were found in the distribution of sex and race/ethnicity 
(table 1). The majority of patients with rare diseases 
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were established patients (93.0%), having been seen by 
the PCP more than one time, and almost half (49.3%) 
were enrolled in private insurance programmes. Of the 
visits for patients diagnosed with a rare disease, 39.0% 
visited their PCPs with a comorbid chronic problem. In 
addition, they had a significantly higher total number 
of chronic diseases compared with patients without rare 
diseases (p<0.01) (table 1).
Of visits by patients with rare disease, 14.3% were 
referred to other providers (table 2). While PCPs spent 
slightly more time with their patients who had rare diseases 
(22.4 min), compared with patients without rare diseases 
(21.3 min), it was not significantly different (table 2). The 
majority of visits for patients with rare diseases and more 
common diseases who were seen by PCPs were located in 
urban areas. PCPs practising in rural areas (7.6%) were 
not significantly less likely than PCPs practising in urban 
areas (16.8%; p=0.06) to refer patients with rare diseases 
to another physician. In a bivariate analysis, care for rare 
disease was also not associated with rurality (p=0.32) 
(table 2).
In an unadjusted regression model, patients with 
rare diseases were 69% more likely to be referred to 
other providers than those without rare diseases. After 
controlling for covariates, such as patients’ characteris-
tics (ie, age, sex, race/ethnicity, types of insurance, major 
reason for this visit, total number of chronic disease, 
having a rare disease and established or new patient), 
patients with rare diseases were 52% more likely to be 
referred to another provider than those without rare 
diseases (table 3).
DIsCussIOn
This study found that few patients with a rare disease 
were identified as being managed in primary care prac-
tice. Patients with rare diseases in the primary care setting 
show significantly older and have more comorbidities 
compared with those without a rare disease diagnosis 
whereas patients with rare diseases are comparable to 
those without rare diseases in terms of sex distribu-
tion, race/ethnicity and types of health insurance. Not 
Table 1 Characteristics of patients with rare diseases in 
primary care, National Ambulatory Medical Care Survey 
2012–2014 (unweighted n=22 306, weighted n=354 507 772)
Patients 
with rare 
diseases
(%)
Patients 
without rare 
diseases
(%) P value
Unweighted sample size 363 21 943
Weighted sample size 5 581 791 348 925 981
Mean age (years)* 47.7 39.4 <0.001
Sex
  Female 56.4 53.8 0.44
Race
  Non-Hispanic White 75.0 70.6 0.54
  Non-Hispanic Black 8.6 10.1
  Hispanics 11.7 14.3
  Others 4.7 5.0
Insurance types
  Private insurance 49.3 54.6 0.15
  Public insurance 47.3 40.0
  Self-pay 1.8 3.5
  Other 1.5 1.9
Major reasons for this visit*
  New problems 33.7 42.6 0.002
  Chronic problems 39.0 28.7
  Presurgery/
postsurgery
27.3 28.7
  Preventive care 0.0 0.0
Total number of chronic 
diseases*
1.3 1.0 0.001
*Statistical significant level at 0.05.
Table 2 Practice characteristics of primary care physicians 
who care for patients with rare diseases using National 
Ambulatory Medical Care Survey, 2012–2014
Patients 
with rare 
diseases
Patients 
without rare 
diseases P value
Practising area
  Urban 84.5 86.4 0.32
  Rural 15.5 13.6
Referral to other 
providers*
  Yes 14.3 9.0 0.01
  No 85.7 91.0
Time spent with 
providers (min)
22.4 21.3 0.09
*Statistical significant level at 0.05.
Table 3 ORs of referral using unadjusted and adjusted 
logistic regression analyses using National Ambulatory 
Medical Care Survey, 2012–2014
Unadjusted OR
(95% CI)
Adjusted OR
(95% CI)
Not having a rare 
disease
Reference Reference
Having a rare 
disease
1.69 (1.15 to 2.48)* 1.52 (1.01 to 2.28)*†
*Statistical significant level at 0.05.
†Controlled for age, gender, race/ethnicity, types of insurance, 
major reason for this visit, total number of chronic disease, having 
a rare disease and established versus new patient.
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surprisingly, visits in primary care for patients diagnosed 
with rare diseases are more likely than patients without 
rare diseases to lead to referral to another provider. To 
our knowledge, this is the first study to investigate charac-
teristics of patients with rare diseases seen in primary care 
practice and the association between physician referral 
and rare disease diagnosis.
Much of medical practice and the corresponding 
comfort in diagnosing and treating conditions is affected 
by the frequency of occurrence of the condition and 
pattern recognition. Rare diseases are by their very 
nature uncommon and thus PCPs may not always feel 
comfortable with the nuances of treatment and potential 
complications for a disease that they encounter very infre-
quently. According to the National Academy of Medicine, 
since rare diseases tend to accompany multiple common 
conditions, it disrupts a clinician’s ability to recognise 
clues of rare diseases.8 In many of these cases PCPs need 
more than a consult from a specialist, especially when the 
primary care team does not have the specialised medical 
knowledge. Receiving all of their care from specialists 
may not be the best situation for the patient. Patients with 
rare diseases need to be managed in primary care or at 
least have shared care between primary care and special-
ists in complementary roles to provide a more effective 
management of these complex patients.
There are some limitations to this study. First, due to 
the design of the NAMCS we are limited to the actions 
recorded in that one visit. The design does allow us to 
have an understanding of the types of patients seen in 
primary care but it is not data on a cohort of patients. 
Thus, we do not know what sort of care may have trans-
pired between the patient and the physician in previous 
visits. Also, it is not able to explore the linkage of multiple 
consultations with specialists previsit or postvisit to PCPs. 
Second, we are able to see if patients are referred in that 
one visit, we are unable to determine if that referral is for 
a consult or part of a shared care relationship between 
primary care and specialty care.
COnClusIOn
This study identified characteristics of patients with rare 
diseases who are seen in primary care practice and the 
delivery patterns of PCPs managing patients with rare 
diseases. Findings from this study suggest that PCPs 
must possess a broad scope of practice in order to deliver 
comprehensive, high-quality care. A better understanding 
of the overall management of patients with rare diseases 
managed solely outside of primary care would help to 
improve the care for these patients.
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